Chloasma--the mask of pregnancy.
Bolanca I, Bolanca Z, Kuna K, Vuković A, Tuckar N, Herman R, Grubisić G.
Coll Antropol. 2008 Oct;32 Suppl 2:139-41.
Melasma: Updates and perspectives.
Kwon SH, Na JI, Choi JY, Park KC.
Exp Dermatol. 2019 Jun;28(6):704-708. doi: 10.1111/exd.13844. Epub 2018 Dec 21.
Melasma.
Doolan BJ, Gupta M.
Aust J Gen Pract. 2021 Dec;50(12):880-885. doi: 10.31128/AJGP-05-21-6002.
Melasma, a photoaging disorder.
Passeron T, Picardo M.
Pigment Cell Melanoma Res. 2018 Jul;31(4):461-465. doi: 10.1111/pcmr.12684. Epub 2018 Jan 12.
The top 10 cosmeceuticals for facial hyperpigmentation.
Searle T, Al-Niaimi F, Ali FR.
Dermatol Ther. 2020 Nov;33(6):e14095. doi: 10.1111/dth.14095. Epub 2020 Sep 4.
The pathogenesis of melasma and implications for treatment.
Artzi O, Horovitz T, Bar-Ilan E, Shehadeh W, Koren A, Zusmanovitch L, Mehrabi JN, Salameh F, Isman Nelkenbaum G, Zur E, Sprecher E, Mashiah J.
J Cosmet Dermatol. 2021 Nov;20(11):3432-3445. doi: 10.1111/jocd.14382. Epub 2021 Aug 19.
Melasma Treatment: An Evidence-Based Review.
McKesey J, Tovar-Garza A, Pandya AG.
Am J Clin Dermatol. 2020 Apr;21(2):173-225. doi: 10.1007/s40257-019-00488-w.
Application of PRP in Chloasma: A Meta-Analysis and Systematic Review.
Deng T, Cheng F, Guo S, Cheng H, Wu J.
Comput Intell Neurosci. 2022 Apr 7;2022:7487452. doi: 10.1155/2022/7487452. eCollection 2022.
Future therapies in melasma: What lies ahead?
Sarkar R, Bansal A, Ailawadi P.
Indian J Dermatol Venereol Leprol. 2020 Jan-Feb;86(1):8-17. doi: 10.4103/ijdvl.IJDVL_633_18.
Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies.
Rajanala S, Maymone MBC, Vashi NA.
Dermatol Online J. 2019 Oct 15;25(10):13030/qt47b7r28c.
